Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3356608 | 1.00 | THRB (0.45) | THRBATMF2SMN1; SMN2HTT | |
| SCHEMBL18406245 | 0.97 | THRB (0.44) | THRBATMF2SMN1; SMN2HTT | |
| SCHEMBL3358506 | 0.97 | THRB (0.44) | THRBATMF2SMN1; SMN2HTT | |
| SCHEMBL3358513 | 0.97 | THRB (0.44) | THRBATMF2SMN1; SMN2HTT | |
| SCHEMBL3357820 | 0.95 | THRB (0.43) | THRBATMF2SMN1; SMN2HTT | |
| SCHEMBL3356143 | 0.95 | THRB (0.43) | THRBATMF2SMN1; SMN2HTT | |
| SCHEMBL3356133 | 0.95 | THRB (0.43) | THRBATMF2SMN1; SMN2HTT | |
| SCHEMBL3357665 | 0.95 | THRB (0.43) | THRBATMF2SMN1; SMN2HTT | |
| SCHEMBL3357812 | 0.95 | THRB (0.43) | THRBATMF2SMN1; SMN2HTT | |
| SCHEMBL3357673 | 0.95 | THRB (0.43) | THRBATMF2SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | ROLIC AG (CH) | 2019-02-19 | — | — | US | disclosed |
| US-9765235-B2 | Photoaligning material | ROLIC AG (CH) | 2017-09-19 | — | — | US | disclosed |
| EP-2152660-B1 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | ROLIC AG (CH) | 2016-05-11 | — | — | EP | disclosed |
| US-20140162076-A1 | PHOTOALIGNING MATERIAL | ROLIC AG (CH) | 2014-06-12 | — | — | US | disclosed |
| US-20100048849-A1 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | ROLIC AG (CH) | 2010-02-25 | — | — | US | disclosed |
| EP-2152660-A2 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | Rolic AG (CH) | 2010-02-17 | — | — | EP | disclosed |
| WO-2008145225-A2 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | ROLIC AG (CH) | 2008-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | DDC, ALAD, DYNC1LI1 | THRB 4854/4885ATM 2265/4885F2 963/4885 |
| US-20100048849-A1 | PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP | DDC, ALAD, DYNC1LI1 | THRB 4854/4885ATM 2265/4885F2 963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.